H. C. Thomas

3.3k total citations
47 papers, 1.6k citations indexed

About

H. C. Thomas is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, H. C. Thomas has authored 47 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 36 papers in Hepatology and 6 papers in Immunology. Recurrent topics in H. C. Thomas's work include Hepatitis C virus research (33 papers), Hepatitis B Virus Studies (31 papers) and Liver Disease Diagnosis and Treatment (18 papers). H. C. Thomas is often cited by papers focused on Hepatitis C virus research (33 papers), Hepatitis B Virus Studies (31 papers) and Liver Disease Diagnosis and Treatment (18 papers). H. C. Thomas collaborates with scholars based in United Kingdom, Italy and Netherlands. H. C. Thomas's co-authors include Peter Karayiannis, Janice Main, M G Brook, Mark Thursz, Andrew Lever, Mark Wright, Branwen J. Hennig, Luyin Zhang, Sylvia Knapp and Simon Hellier and has published in prestigious journals such as Gut, Journal of Hepatology and British Journal of Haematology.

In The Last Decade

H. C. Thomas

46 papers receiving 1.5k citations

Peers

Countries citing papers authored by H. C. Thomas

Since Specialization

Citations

This map shows the geographic impact of H. C. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. C. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. C. Thomas more than expected).

Fields of papers citing papers by H. C. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. C. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. C. Thomas. The network helps show where H. C. Thomas may publish in the future.

Co-authorship network of co-authors of H. C. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of H. C. Thomas. A scholar is included among the top collaborators of H. C. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. C. Thomas. H. C. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency 2014 ·Metabolic Brain Disease ·David Sheridan, Simon H. Bridge, Mary M.E. Crossey, Daniel J. Felmlee, H. C. Thomas, R. Dermot G. Neely, Simon D. Taylor‐Robinson, M.F. Bassendine	9
2	Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR 2003 ·Genes and Immunity ·Sylvia Knapp, Leland J. Yee, A J Frodsham, Branwen J. Hennig, Simon Hellier, Luyin Zhang, Mark Wright, M. Chiaramonte, Mary C. Graves, H. C. Thomas, Adrian V. S. Hill, Mark Thursz	187
3	Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection 2002 ·Genes and Immunity ·Branwen J. Hennig, Simon Hellier, A J Frodsham, Luyin Zhang, Paul Klenerman, Sylvia Knapp, Mark Wright, H. C. Thomas, Mark Thursz, Adrian V. S. Hill	52
4	Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C 1999 ·Journal of Hepatology ·H. C. Thomas, M. Estée Török, Daniel Forton, Simon D. Taylor‐Robinson	52
5	Mechanism of emergence of hepatitis B virus escape variants: approaches to prevention 1998 ·Journal of Viral Hepatitis ·H. C. Thomas	3
6	Immunogenetics of hepatitis B virus infection 1997 ·Journal of Viral Hepatitis ·H. C. Thomas, Mark Thursz	3
7	Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C 1997 ·Journal of Hepatology ·Giovanna Fattovich, G. Giustina, Françoise Degos, G. Diodati, F. Tremolada, Frederik Nevens, Piero Luigi Almasio, Antonio Solinas, Johannes T. Brouwer, H. C. Thomas, G. Realdi, Roberto Corrocher, Solko W. Schalm	161
8	Predicted secondary structure of the hepatitis G virus and GB virus‐A 5‘ untranslated regions consistent with an internal ribosome entry site 1997 ·Journal of Viral Hepatitis ·(unknown), H. C. Thomas, Peter Karayiannis	13
9	Different Relative Activities of Human Cell-Derived Interferon-α Subtypes: IFN-α8 Has Very High Antiviral Potency 1996 ·Journal of Interferon & Cytokine Research ·Graham R. Foster, Osiyallê Akanni Silva Rodrigues, (unknown), Ewert Schulte‐Frohlinde, Douglas Testa, M J Liao, George R. Stark, L. Leadbeater, H. C. Thomas	106
10	The management of chronic hepatitis C virus infection. 1995 ·Gut ·Jonathan Booth, Jonathan Brown, H. C. Thomas	30
11	Implications of genetic variation on the pathogenesis of hepatitis B virus infection 1993 ·PubMed ·William F. Carman, H. C. Thomas	2
12	Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment 1990 ·Journal of Hepatology ·Peter Karayiannis, (unknown), H. C. Thomas	9
13	The hepatitis B virus and the host response 1990 ·Journal of Hepatology ·H. C. Thomas	30
14	Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection. 1989 ·BMJ ·M G Brook, (unknown), I. Yap, Peter Karayiannis, Andrew Lever, M R Jacyna, Janice Main, H. C. Thomas	68
15	Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response. 1989 ·Gut ·M G Brook, J.A. McDonald, Peter Karayiannis, L. Caruso, G E Forster, J R Harris, H. C. Thomas	80
16	Treatment of thrombocytopenia with alfa interferon. 1987 ·BMJ ·Andrew Lever, M G Brook, I. Yap, H. C. Thomas	27
17	Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection. 1986 ·Gut ·Tadashi Ikeda, Massimo Pignatelli, Andrew Lever, H. C. Thomas	22
18	Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen 1985 ·BMJ ·Peter Karayiannis, (unknown), Anna S. Lok, Martin Fowler, (unknown), H. C. Thomas	3
19	Transfer factor in the attempted treatment of patients with HBsAg-positive chronic liver disease. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·S Jain, H. C. Thomas, S. Sherlock	18
20	[Treatment of fever and influenza infections using Chinavit]. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·H. C. Thomas	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact